In 2025, many authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.
Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspectives and insightful views as authors.
Outstanding Authors (2025)
Fangdi Sun, Stanford University, USA
Linda Hammerich, Charité Universitaetsmedizin Berlin, Germany
Ari Kassardjian, City of Hope National Medical Center, USA
Takafumi Hayashi, Kawasaki Medical School, Japan
Yajnavalka Banerjee, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai
Shirin Davarpanah Jazi, BrainCool AB, Sweden
Sung Ryul Shim, Konyang University, Korea
Yuzhuo Wang, The University of British Columbia, Canada
Cora N. Sternberg, New York-Presbyterian, USA
Benoit Jacques Bibas, The University of São Paulo, Brazil
Hazem Aboaid, University of Nevada, Las Vegas, USA
Piotr Rutkowski, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Sacha I. Rothschild, the Cantonal Hospital Baden, Switzerland
Armen Parsyan, Western University, Canada
Benjamin A. Teply, The University of Nebraska Medical Center, USA
Bartłomiej Tomasik, Medical University of Gdańsk, Poland
Antonio Ruggiero, Università Cattolica del Sacro Cuore in Rome, Italy
Nicole C. Schmitt, Winship Cancer Institute, USA
Amanda Herrmann, University of California San Diego (UCSD), USA
Outstanding Author
Fangdi Sun
Dr. Fangdi Sun is the Chief Fellow for the Hematology & Medical Oncology fellowship at Stanford University. She received her BS in Bioengineering from the Massachusetts Institute of Technology, followed by her MD from Harvard Medical School. She then completed her Residency and Chief Residency in Internal Medicine at the University of California, San Francisco prior to coming to Stanford. She is establishing an academic career as a clinical investigator in Thoracic / H&N medical oncology. Her research interests include targeted therapies in NSCLC, virus-driven malignancies, and the appropriate use of circulating tumor DNA in the early-stage setting.
TCR: What are the essential elements of a good academic paper?
Dr. Sun: The building blocks of strong academic writing start well before the first word is written. The author needs to understand the landscape of existing knowledge in their field, and how the topic they plan to address, even if highly specific, will fit into and contribute to this body of knowledge. For original research, the data elements, collection methods, and analysis plan should be clearly defined a priori, then followed in a rigorous manner to ensure data quality and minimize bias. For review articles or editorials, the authors should have an idea of who their intended audience is in order to best structure and summarize the topic of interest. Finally, the best academic papers are often ones where the figures (and occasionally the tables) tell most of the story. When it comes down to the actual writing, most of the hard work should already have been done.
TCR: What are the key skill sets of an author?
Dr. Sun: Patience and perseverance are the most important characteristics of an academic author, but also some of the hardest skills to learn. The obvious interpretation is that science is a series of successes and failures, as anyone who has tried to publish a peer-reviewed article knows the experience of having a manuscript rejected by one or many journals. Yet more importantly, being willing to put pen to paper is critical, whether with the first iteration of a study concept or the first draft of a manuscript. Then having the patience to go back and iterate upon this can be even more challenging. The most successful people are willing to go out on a limb in the beginning, not letting perfection be the enemy of good.
TCR: Is there any interesting story during academic writing that you would like to share with us?
Dr. Sun: I am always impressed by patients’ willingness to have their stories told through the lens of an academic case report. While I have often worried that patients will object to having specific details of their individual treatment experience shared publicly, the near-universal answer is one of immediate agreement. Behind this answer is a sense of altruism – a hope that such information will help someone else in their position. When possible, the ability to share the published case report with the patient or family is particularly meaningful. In general, I view this as a reminder that we have a responsibility to share information back to patients, the most important partners in what we do.
(by Sasa Zhu, Brad Li)
Linda Hammerich
Dr. Linda Hammerich is the head of the Tumor Immunology and Immunotherapy Lab at the Department of Hepatology and Gastroenterology at Charité Universitaetsmedizin Berlin (Berlin, Germany). She is an immunologist by training with a strong background in chronic liver diseases and high-throughput single-cell methods. Her scientific interests include developing and improving immunotherapies for gastrointestinal cancers and immune monitoring of cancer patients using full spectrum flow cytometry and mass cytometry. She is also researching and developing refinement measures to improve animal welfare in preclinical studies.
Dr. Hammerich believes that academic writing is an essential tool for sharing knowledge, communicating ideas with peers, and developing critical thinking skills. It helps to express complex ideas in a clear and precise manner and allows researchers to document research findings and developments over time. Sharing ideas, theories, and results (even negative ones) builds and advances the knowledge base within a particular field and drives the development of new ideas and concepts. Academic writing also encourages critical thinking, engaging with the work of others, and challenging one’s own thoughts, which is crucial for personal growth as a researcher.
In Hammerich’s view, critical writing involves questioning and analyzing ideas or concepts carefully to draw well-informed conclusions. It is crucial to consider multiple perspectives, including but not limited to one’s own, and to consider the context in which information or evidence is presented. She adds, “Be not just descriptive, but examine ideas or assumptions, question them, and point out strengths and weaknesses. Critical writing often suggests alternative solutions rather than merely highlighting flaws. It also requires self-awareness to recognize personal biases and their potential influence on your writing. Finally, be as clear and precise as possible and present a logical and focused analysis of the data.”
(by Sasa Zhu, Brad Li)
Ari A. Kassardjian
Ari Kassardjian is a 4th year radiation oncology resident at City of Hope National Medical Center. He received a Bachelor of Science from Georgetown University in Washington, DC, followed by his MD from Keck School of Medicine of the University of Southern California. His research interests include CT- and MR-based online adaptive radiotherapy, expanding indications of radiation for cutaneous malignancies, and long-term patient reported outcomes in head and neck cancer. His recent research includes a prospective analysis of patient perceptions and expectations of radiation therapy before and after consultation. Additionally, he is working on a project evaluating patterns of breast cancer recurrence following neoadjuvant systemic therapy to assess whether a subset with low-risk residual disease may benefit from partial breast irradiation. His other research interests include changes in patient characteristics and demographics over time, expanding healthcare delivery and access to medically underserved communities, and patient education. Connect with Dr. Kassardjian on X.
In Dr. Kassardjian’s opinion, having a clearly defined research question and easily interpretable figures, both supported by robust data, represent the most important aspects of writing an academic paper. In addition, a strong paper should be written in a way that is accessible to a broad audience, including those not directly involved in the field. Double- and triple-checking one’s work for clarity, grammar, and syntax can help ensure other key components, such as a comprehensive literature review, structured methodology, and a discussion highlighting the significance and implication of one’s findings, shine through effectively.
On the other hand, Dr. Kassardjian highlights the importance of following reporting guidelines when writing a manuscript. Guidelines, such as SROBE and PRISMA, standardize the data reporting process, and ensure thoroughness, clarity, and transparency. Although research projects can generate interesting results, those results should be reproducible, and reporting guidelines are an important avenue for collaboration with researchers from other institutions or countries.
“The most important piece of advice I want to give to others engaging in scientific research is to always remain open-minded and curious. No matter what stage of education, training, or research that I am in, there is always something new to learn, and I never assume that I know everything. Always be open, humble, and receptive to help and advise. Establish mentors and ask for feedback early. Collaboration is key; engage with your peers, share your findings, and be willing to learn from others. Finally, remember that setbacks are part of the journey, but they often lead to the most significant breakthroughs!” says Dr. Kassardjian.
(by Brad Li, Masaki Lo)
Takafumi Hayashi
Takafumi Hayashi, MD, PhD, is the Associate Professor of Radiation Oncology at Kawasaki Medical School, and Director at the Center for Radiation Therapy, Department of Radiology, Kawasaki Medical School General Medical Center. His research area covers Thoracic Radiation Oncology. Recently, his research focuses on metastasis-directed therapy for oligometastasis. This new approach involves targeting specific metastatic tumors with precision therapies to control cancer spread and improve patient outcomes. Dr. Hayashi received his Ph.D. from the Faculty of Medicine at Shimane University and has over 10 years of experience as a certified diagnostic imaging specialist. He was later qualified as a radiation oncologist. In his clinical practice, he prioritizes building trusting relationships with his patients and providing personalized treatment plans that make full use of the latest technology. Since 2016, he has been focusing on comprehensive and precise radiation therapy at Kawasaki Medical School. In addition to clinical practice and research, he also finds joy in teaching students.
In Dr. Hayashi’s opinion, effective medical writing requires several key skills. First, strong communication skills are essential. Clearly and systematically expressing complex medical ideas requires concise and well-organized writing. This ensures that research findings are presented in a way that is easy for readers to understand. Second, analytical skills play a vital role. A deep understanding of research methods and basic statistical principles, along with the ability to think critically and interpret data accurately, is crucial. These skills enable authors to thoroughly analyze their data and draw reliable, evidence-based conclusions. Finally, he believes that patience, paired with a desire to continuously learn, is equally important. Writing a quality paper often involves multiple rounds of revisions, which demand persistence. Additionally, staying up to date with the latest advancements and technologies in the medical field ensures that the research remains practical, valuable, and aligned with current needs and challenges.
Bias in medical publications can distort the interpretation of research, so it is crucial, according to Dr. Hayashi, to approach writing with a commitment to objectivity and clarity. To achieve this, he believes it is essential to rigorously gather and verify information using reliable sources, and then present findings in careful, neutral language—avoiding overly emotional phrases or stereotypes. Additionally, welcoming feedback from a wide range of colleagues not only enriches the perspective of the work but also helps ensure that the final publication maintains a high standard of credibility. By incorporating these practices into the writing process, researchers can produce medical literature that is both trustworthy and effective.
“Academic writing, while requiring considerable time and effort, is a deeply fulfilling endeavor. Driven by a deep curiosity, I am motivated to share knowledge that will enhance medical care and positively impact health outcomes. Moreover, the process of writing fosters the exchange of ideas and the development of critical thinking skills, both of which I find intrinsically rewarding. These elements collectively support my motivation to pursue academic scholarship,” says Dr. Hayashi.
(by Brad Li, Masaki Lo)
Dr. Yajnavalka Banerjee is an Associate Professor of Biochemistry at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Dubai, UAE. With a PhD from the National University of Singapore and postdoctoral fellowships at The Scripps Research Institute and Max Planck Institute, he holds distinguished recognitions, including the NIH and Alexander von Humboldt Fellowships. His research spans venom-derived therapeutics, cardiovascular disease, and colorectal cancer, with a recent focus on protease-activated receptor-2 (PAR-2) signaling, statin repurposing, and nutraceuticals in inflammation. He is the principal investigator of several funded studies, including those by Pfizer and Amgen, and is actively exploring AI-integrated pharmacogenomics. A prolific author with over 90 peer-reviewed publications and multiple patents, he also plays a pivotal role in medical education innovation, curriculum design, and student mentorship. He serves on the editorial boards of several high-impact journals and is committed to translating basic science into therapeutic strategies that address regional and global health priorities.
Dr. Banerjee believes a good academic paper presents a clearly defined research question, supported by rigorous methodology, robust data, and critical analysis. It must demonstrate originality, relevance to the field, and contextual depth by engaging with current literature. In translational cancer research, a strong paper bridges basic science and clinical application, offering insights with potential therapeutic impact. Clarity of presentation, reproducibility of results, and a coherent narrative from hypothesis to conclusion are essential. Finally, the study should acknowledge limitations and propose future directions that align with advancing patient care or mechanistic understanding.
From Dr. Banerjee’s perspective, authors must ensure clarity, accuracy, and scientific rigor throughout the manuscript. In translational cancer research, aligning the study with clinical relevance is key. A well-structured paper should include a compelling rationale, detailed methodology, and statistically sound results. Authors must use appropriate controls, justify experimental models, and interpret findings within the broader scientific context. Ethical compliance, transparency in data reporting, and proper referencing are critical. Attention to journal-specific guidelines, figure quality, and language precision enhances readability and impact. Lastly, authors should clearly articulate how their findings advance translational insight or therapeutic innovation in cancer research.
“The pursuit of discovery and the potential to contribute meaningfully to patient outcomes drive my academic writing. In translational cancer research, the opportunity to bridge laboratory findings with clinical relevance is deeply fulfilling. Writing allows me to distill complex data into insights that can inform therapy, guide future research, and inspire collaboration. The process, though demanding, sharpens critical thinking and fosters intellectual growth. Ultimately, the motivation lies in knowing that each well-crafted paper is a step toward innovation, impact, and advancing science in service of humanity,” says Dr. Banerjee.
(by Sasa Zhu, Brad Li)
Shirin Davarpanah Jazi
Dr. Shirin Davarpanah Jazi completed her PhD in Human Motor Control at Western University, Canada, in 2016, followed by a one-year postdoctoral fellowship at the same institution. Afterward, she pursued a degree in Physiotherapy at McMaster University, Canada. Due to family reasons, she relocated to Sweden, where she began working as a Clinical Support Manager at BrainCool AB, focusing on projects related to concussion and oncology. Her current focus is on the prevention of chemotherapy-induced peripheral neuropathy and oral mucositis. She collaborates closely with research teams in Basel, Switzerland, and Umeå, Sweden, to advance her work in these areas. Connect with her on LinkedIn.
Dr. Jazi believes academic writing is one of the most important ways to deepen researchers’ understanding of the world around them and a powerful means for scientists to share their voices globally. She sees it as the official language of science. To her, academic writing is crucial for both explaining a subject and analyzing its significance. A critical approach in writing entails analyzing the topic from various perspectives, considering both positive and negative aspects, while steering clear of bias, subjectivity, and unsupported personal opinions.
(by Sasa Zhu, Brad Li)
Sung Ryul Shim
Dr. Sung Ryul Shim is an assistant professor of Biomedical informatics at Konyang University College of Medicine, Daejeon, Korea. He received his PhD degree and his Master of Public Health from Korea University College of Medicine in Seoul, Korea. His main research area is Systematic Review and Meta-Analysis, which has published 10 academic books and around 150 SCI journal articles. For the second consecutive year from 2023 to 2024, he is the world's top 2% scientist by Elsevier and Stanford University. His research interests include network meta-analysis, diagnostic test meta-analysis, and dose-response meta-analysis, with a broad understanding of advanced meta-analysis methodologies. Internationally, he collaborates with many national and international research networks, including Harvard, Yale, the National Cancer Institute, Stanford, University of Toronto, University of Vienna, Imperial College London, University of Warsaw, and Shiraz University.
TCR: What do you regard as a good academic paper?
Dr. Shim: I honestly don't know what I consider to be good research. I simply strive to use all of my knowledge to communicate scientific facts accurately and without bias. I believe that the accumulation of rigorous scientific knowledge by individuals has enabled humanity to develop the vast collective intelligence we have today. When communicating scientific facts, individuals should ensure thorough verification and objective messaging, even if they are mistaken in some areas.
TCR: Scientific progress occurs rapidly, so how do you ensure your writing remains current and offers fresh insights into the research field?
Dr. Shim: Leveraging relevant health informatics technologies, such as generative AI, is a great way to keep your internal knowledge up to date. Of course, the best way to do this is to stay connected with your audience through publications and continued research.
TCR: Would you like to share with us your experience publishing in TCR?
Dr. Shim: The whole process from submission to TCR to review was very interesting for me, for example, the reviewer process was like nothing I have ever experienced before, with more than 40 emails back and forth over 8 months and thorough validation to publication. This review process will ensure high credibility with readers.
(by Sasa Zhu, Brad Li)
Yuzhuo Wang
Dr. Yuzhuo Wang is a Distinguished Scientist at BC Cancer, a Professor in the Department of Urologic Sciences at the University of British Columbia, and a Fellow of the Canadian Academy of Health Sciences. Internationally recognized for his pioneering work in prostate cancer (PCa), he focuses on treatment resistance and cancer dormancy. He established widely used patient-derived xenograft models and has made significant contributions to understanding the progression from hormone-naïve PCa to castration-resistant PCa, including neuroendocrine PCa. He has published over 240 peer-reviewed papers, edited two books, and holds an H-index of 87, reflecting the broad impact of his research. His recent projects include the development of novel small molecule inhibitors targeting MCT4 to disrupt cancer-driven lactic acid metabolism and restore anti-tumor immunity. He also leads interdisciplinary initiatives to identify, characterize, and therapeutically target dormancy-capable and dormant cancer cells that drive cancer relapse—advancing his vision of a “cancer fear-free world.” Connect with him on LinkedIn.
According to Dr. Wang, academic writing is essential to science because it transforms discoveries into shared and enduring knowledge. It allows researchers to clearly communicate their findings, facilitating critical evaluation, replication, and refinement by others in the field. This exchange of information is the backbone of scientific progress, ensuring that knowledge does not remain isolated but contributes to a broader understanding. Through peer-reviewed publications, academic writing establishes the credibility of scientific claims by subjecting them to rigorous scrutiny and validation. It also provides a permanent and accessible record of research that others can build upon, fostering innovation, collaboration, and interdisciplinary breakthroughs. Importantly, writing forces scientists to think deeply and systematically about their data, often leading to new interpretations or ideas. Academic writing is not just a means of dissemination; it is a crucial component of the scientific method, aiding in the refinement of ideas, challenging assumptions, and advancing human knowledge.
To keep the writing current, Dr. Wang engages with emerging literature, attends scientific conferences, and maintains dialogue across disciplines. Yet, he believes that true innovation stems from identifying and tackling the most pressing, unresolved challenges in cancer research. He deliberately focuses on complex, high-risk areas often overlooked, as they offer the greatest potential for transformative impact. Instead of following established paradigms, he strives to generate original insights—both conceptually and technologically. Through critical thinking and scientific curiosity, he aims not just to keep pace with progress, but to help shape the future direction of cancer research.
“I am driven by the belief that impactful science must be shared to create meaningful and lasting change. Academic writing serves not only as a communication tool but also as a cornerstone of scientific advancement.For me, writing serves as both a responsibility and a craft, allowing our work to be critically assessed, replicated, and utilized to advance the field. What motivates me most is knowing that our findings—even if incremental—can shape how cancer is understood, diagnosed, and treated. Each manuscript is an opportunity to challenge assumptions, raise new questions, and contribute to future therapeutic strategies. As someone deeply engaged in translational cancer research, I find particular purpose in bridging laboratory discoveries with clinical impact. The potential to improve outcomes for patients with lethal or treatment-resistant disease makes the time and effort invested in writing not only worthwhile but profoundly meaningful,” shares Dr. Wang.
(by Sasa Zhu, Brad Li)
Cora N. Sternberg
Dr. Cora N. Sternberg is a Professor of Medicine and Clinical Director of the Englander Institute for Precision Medicine (EIPM) at Weill Cornell Medicine (WCM), New York-Presbyterian, in New York. She is a globally respected leader in medical oncology and urological malignancies. She has served as the PI for numerous studies and is renowned for her lectures at universities and cancer symposia worldwide, delivering over 835 lectures. Her groundbreaking work in bladder cancer, prostate cancer, and renal cell carcinoma has had a significant impact on the field. She has published extensively, with 546 articles and 6 textbooks, and serves as an associate editor and editorial board member for several international journals. She ranks in Stanford University's "World's Top 2%" of scientists and has over 45,200 citations of her articles, placing her in the top 5% for citations within the Doximity community. She has chaired major scientific international meetings and has been on the educational committee of ESMO. She was elected to the executive board of the EORTC and serves as a core faculty member of the ESO. She was elected chairman of the nominating committee of ASCO’s board of directors. She acts as the liaison between the EIPM, WCM, New York-Presbyterian, New York, and the Meyer Cancer Center, bridging innovative research and clinical practice. She has a particular interest in AI and a long-standing commitment to clinical and translational research, and the development of new therapies, and an interest in AI.
In Dr. Sternberg’s view, serious academic writing is essential to science because it enables researchers to share their peer-reviewed work that has been rigorously performed in a clear and honest way. It spreads knowledge and moves science forward.
To keep the work current and contribute valuable insights, Dr. Sternberg stays updated by attending scientific conferences, reading leading journals, and constantly interacting with her colleagues both at her hospital and globally. She also tries to do work that will answer a scientific question, fill a knowledge gap, or bring a new perspective supported by solid evidence. She often seeks feedback from her peers to ensure relevance and originality.
“I am motivated to write by the opportunity to contribute meaningfully to scientific knowledge, influence clinical practice, and engage in academic work that drives the field forward. Publishing my research has led to collaboration, recognition, and the opportunity to mentor and inspire the next generation of scientists,” says Dr. Sternberg.
(by Sasa Zhu, Brad Li)
Benoit Jacques Bibas
Dr. Benoit Jacques Bibas is an Assistant Professor of Surgery at the University of São Paulo and a thoracic surgeon at the Heart Institute (InCor-HCFMUSP), Brazil. His clinical and academic focus lies in complex airway surgery, particularly tracheal and bronchoplastic procedures. He has led and collaborated on several prospective and multicenter studies, including those examining surgical outcomes after tracheal resection and airway reconstruction, as well as the impact of neoadjuvant therapies on thoracic oncology. In addition to his clinical work, he actively contributes to the scientific community as a reviewer for leading medical journals and has presented his research at international conferences. His current projects also explore patient-reported outcomes and surgical innovation in minimally invasive airway procedures.
In Dr. Bibas’s view, academic writing is essential for the dissemination of knowledge, validation of scientific findings, and advancement of evidence-based medicine. It allows researchers and clinicians to share discoveries, challenge existing paradigms, and contribute to the continuous improvement of patient care. Through academic writing, clinical experience is transformed into structured, reproducible knowledge that can be critically appraised and used globally. In a field as dynamic as thoracic surgery, where innovations rapidly evolve, academic writing ensures that advancements are accessible, verifiable, and impactful.
Dr. Bibas thinks a good author should be intellectually honest, methodologically rigorous, and committed to clarity. The ability to synthesize complex data into coherent, structured arguments is fundamental. Additionally, humility to accept criticism, perseverance in revising manuscripts, and curiosity to continuously seek better questions and methods are essential traits. Beyond technical skills, authors must also recognize the responsibility of ensuring their work serves both scientific progress and patient benefit.
Writing scientific papers amidst a demanding clinical schedule requires discipline and prioritization. Dr. Bibas treats writing as an integral part of his clinical mission rather than a separate task—it is a way of reflecting on outcomes, improving care, and contributing to the field. He often uses early mornings or late evenings for writing and maintains structured timelines for ongoing projects. Collaborating with a dedicated and organized team also helps to share responsibilities and maintain academic productivity without compromising patient care.
(by Sasa Zhu, Brad Li)
Hazem Aboaid
Dr. Hazem Aboaid completed medical school at Homs University Faculty of Medicine (formerly known as Al-Baath University) in Syria. He completed an internal medicine residency at the Kirk Kerkorian School of Medicine at the University of Nevada, Las Vegas (June 2025). He is starting a new job as a hospitalist at Antelope Valley Medical Center in Lancaster, California, in September 2025. He also applied to the Hematology and Medical Oncology Fellowship this year. His research interests include efficacy and safety of novel cancer-targeted therapies. His most recent project was a review article published in Frontiers in Immunology (June 2025) about the most recent updates regarding immunotherapy in the treatment of head and neck cancer. Connect with him on LinkedIn.
Dr. Aboaid thinks a good academic paper is built on several essential elements that work together to communicate ideas clearly. First, it should present a well-defined thesis or research question that guides the scope and direction of the study. The argument has to be supported by a logical structure, with each section contributing to the overall narrative. Strong academic writing also relies on extensive research, critical engagement with existing literature, and accurate citation of sources to establish credibility and context. Clarity, coherence, and precision in language are crucial, as they help readers follow complex ideas without ambiguity. Finally, a good paper reflects originality—whether through new insights, methods, or interpretations—and contributes meaningfully to the academic conversation in its field.
Dr. Aboaid emphasizes several key considerations for authors when preparing a scientific paper. First, it is highly important to do an extensive literature search and be familiar with the most recent updates and existing knowledge in their area. That helps in writing the paper to fill gaps in the literature and add to it. Understanding the target journal's scope, audience, and formatting requirements based on the article type is essential. Authors should also maintain a clear and focused argument throughout the paper, supported by robust methodology and evidence. Attention to detail in referencing, adherence to ethical research practices, and avoidance of plagiarism are essential. Additionally, authors should write with clarity and conciseness, anticipating potential questions from readers and reviewers. Revising the manuscript multiple times—with attention to both content and language—helps refine the paper and strengthens its overall impact. Authors should prepare for possible rejection by one or several journals. Although this can be frustrating and challenging, it should motivate them to refine their work further and continue making contributions to their research field.
“To all my colleagues in the medical field who have been dedicating themselves to advancing scientific progress, your hard work is vital and deeply appreciated. Research is how we can change medical practice, guidelines, and ultimately our patients’ lives. All of us need to keep contributing to this pivotal area of medicine. Your persistence, curiosity, and commitment are what drive innovation and inspire future generations of scholars. Keep up all the hard work, science thrives because of voices and minds like yours,” says Dr. Aboaid.
(by Sasa Zhu, Brad Li)
Piotr Rutkowski
Dr. Piotr Rutkowski is Professor of Surgical Oncology at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland. He is the current Head of the Department of Soft Tissue/Bone Sarcoma and Melanoma (which is a reference center for sarcoma and melanoma in Poland), the Plenipotentiary of the Head Director of the Institute for National Oncological Strategy and Clinical Trials at the Maria Sklodowska-Curie National Research Institute of Oncology. He has participated in several investigator-driven and sponsored trials in melanoma and sarcoma. He is a reviewer for several international scientific journals, as well as an Editorial Board Member of European Journal of Surgical Oncology and Translational Cancer Research. He was a member of the Steering Committee of 3 trials. He has authored or co-authored over 500 scientific papers in Polish and international journals (with an impact factor of above 4500, index-H: 92, citation index >35000, and named Highly Cited Researcher in Clinical Medicine for 2021, 2022, and 2023), and is a co-author of national and international recommendations for sarcoma and melanoma. He is working very closely with national patient advocacy groups for GIST/sarcoma and melanoma, coordinating the Polish Sarcoma Group, and is Chairman of the Melanoma Academy in Poland. His research activities focus on new treatment modalities and translational research in melanoma and sarcoma. Connect with him on LinkedIn.
TCR: What role does academic writing play in science?
Dr. Rutkowski: Academic writing is vital for science to disseminate research results, allow for interpretations, and exchange opinions. Review papers, in the era of abundant scientific information, can provide detailed analysis and critical opinion on recent research. Writing papers is an important part of the education of new scientists and may tighten the cooperation between new generations and their tutors.
TCR: Science advances rapidly day by day. How do you ensure your writing is up-to-date and can give new insights into the field of research?
Dr. Rutkowski: As someone who is considered an expert in the field, I feel it is my responsibility to stay informed about the latest advancements in melanoma and sarcoma. I achieve this by attending major conferences, reviewing journal publications, and engaging with my colleagues who are also professionals in this area. Personally, I participate in several international research initiatives and major clinical trials.
TCR: Academic writing takes a lot of time and effort. What motivates you to do so?
Dr. Rutkowski: I agree, but I still strongly believe that it is my obligation to report the results of our research in the form of full papers, prepare critical views on new data, and help other, less experienced, colleagues when publishing a chapter or full book on a specialized topic.
(by Sasa Zhu, Brad Li)
Sacha I. Rothschild
Sacha Rothschild, MD, PhD, is a professor of Medical Oncology at the University of Basel and head of the Department of Oncology / Haematology and the Cancer Center at the Cantonal Hospital Baden (Kantonsspital Baden), Switzerland. As a physician-scientist, his research focuses on thoracic oncology, precision medicine, and immunotherapy. He plays a key strategic and scientific role at the Swiss Cancer Institute (formerly known as Swiss Group for Clinical Cancer Research, SAKK), contributing to the development and coordination of national and international clinical trials. He has led numerous clinical trials and is dedicated to translating research findings into clinical benefit for patients. His work emphasizes biomarker-driven therapies and the advancement of personalized cancer treatment. He is also strongly engaged in mentoring young clinicians and scientists, and in fostering equity and excellence in academic medicine. Connect with him on LinkedIn.
Dr. Rothschild thinks academic writing is fundamental for the dissemination of knowledge and scientific advancement. It provides a structured and peer-reviewed way to share new findings, debate ideas, and build on existing evidence. Beyond individual studies, academic writing forms the backbone of evidence-based practice in medicine and science. It fosters transparency, encourages collaboration, and ensures that progress is accessible and reproducible. In short, it transforms scientific discovery into shared knowledge.
In Dr. Rothschild’s view, data sharing is essential in modern scientific research. It enhances transparency, allows for independent verification of results, and accelerates discovery by enabling others to build on existing data. Especially in the medical field, shared data can contribute to larger meta-analyses and collaborative research that ultimately benefit patients. While it is important to respect privacy and ethical considerations, the responsible sharing of data strengthens the credibility and impact of scientific work.
“To all my fellow academic writers: your dedication, precision, and perseverance matter. The path of scientific writing can be long and sometimes frustrating, but every well-written paper contributes to a larger body of knowledge that drives medicine and science forward. Even when the impact is not immediately visible, your work helps shape future discoveries. Stay curious, stay critical, and keep writing,” says Dr. Rothschild.
(by Sasa Zhu, Brad Li)
Armen Parsyan
Dr. Armen Parsyan, MD, PhD, DSc, MPH, FRCSC, FACS, is a Canadian and USA-certified general surgeon with a subspecialty training in breast surgical oncology. He has extensive training and experience in basic, translational, and clinical research from world-renowned institutions, such as Cambridge University, UK (PhD), Boston University (MPH), Harvard and McGill Universities, and the University of Toronto (postdoctoral training). Currently, he is an Assistant Professor at the Departments of Surgery, Oncology, and Anatomy & Cell Biology at Western University and a surgeon-scientist in London, ON, where he leads a translational breast cancer research laboratory at the Verspeeten Family Cancer Centre. His research is supported by Breast Cancer Canada and other prestigious grants and awards. His research focuses on translational breast cancer studies. He utilizes advanced technologies such as spatial omics and CRISPR-Cas9 to investigate the pathogenesis and treatment resistance associated with breast cancer. Additionally, he aims to develop innovative treatment strategies and biomarkers for this disease.
Dr. Parsyan believes that the human drive to understand the world is inherited and crucial for human beings' survival. In a broader sense, academic writing is one of the important means of sharing this understanding and accumulating the knowledge associated with it. In terms of his specific field of cancer research and treatment, finding a coveted cure for cancers is not a one-person effort but rather a product of combined input from clinicians, scientists, patients, and many others. Indeed, this complex adversary requires vast research efforts and can only be achieved through a forum where all researchers share bits and pieces of new knowledge to assemble the Lego of the target we want to strike and to learn about the ways to strike it effectively. In short, academic writing provides that forum. All in all, academic writing is one of humanity’s survival tools, and that is what is so important about it.
Dr. Parsyan emphasizes that strong written communication, the ability to present complex ideas and information in a simple, concise, organized, and logical way are key skills of an author. However, being an outstanding academic writer does not necessarily translate into an outstanding scientist who produces impactful research. For the latter, he believes that strong observational and analytical skills, creativity, imagination, a desire to push the limits of knowledge, a drive to make a meaningful contribution, and perseverance are some of the essential skill sets. If luck and serendipity are on their side, it is a big bonus too.
(by Sasa Zhu, Brad Li)
Benjamin A. Teply
Dr. Benjamin Teply is an Associate Professor in the Division of Hematology/Oncology at the University of Nebraska Medical Center. Before his faculty appointment, he completed a fellowship in medical oncology at Johns Hopkins University, where he also served as Chief Fellow. He is an expert in genitourinary oncology with a particular focus on therapies beyond hormonal suppression for prostate cancer, the use of biomarkers, and the optimization of patient care. He has been recognized for his research achievements, receiving both the University of Nebraska Medical Center's New Investigator Research Award and the Faculty Clinical Research Award. He serves as the Medical Director for the Clinical Trials Office at the Fred & Pamela Buffett Cancer Center.
Dr. Teply believes that a strong academic paper clearly outlines the current knowledge landscape and identifies the specific knowledge gap being addressed in the study. It is clear with the hypothesis being tested, and why those results will help move the field forward, regardless of the outcome. It is explicit with methodology and data sources. He believes that recognizing the strengths and limitations of the paper is essential. The best papers conclude in an understated and cautious manner. Moreover, the best papers clearly acknowledge their limitations and strive to address them as effectively as possible.
Dr. Teply has reviewed numerous papers over the years, and this process has helped him prepare better papers. When writing a paper, he also uses the lens of a reviewer. One should be able to anticipate any potential shortcomings of the study. It is always preferred to proactively discuss shortcomings. This self-awareness of the strengths and limitations of the paper, prior to the peer review process, distinguishes the top authors.
“If writing an academic paper does not come naturally to you, do not despair – it does not come naturally to anyone. Like any skill, it must be learned and honed over time. Engage as a peer reviewer to learn the process. Examine your own paper drafts as if you were a peer reviewer. Any good paper takes multiple iterations. Be reassured that we are making leaps and bounds in terms of scientific progress, and we are doing it through this process of paper dissemination,” says Dr. Teply.
(by Sasa Zhu, Brad Li)
Bartłomiej Tomasik
Dr. Bartłomiej Tomasik graduated from the Medical University of Łódź, Poland, in 2014. In 2019, he defended his PhD thesis, which was recognized by the Polish Society of Clinical Oncology as the best doctoral dissertation of the year. He also completed the Postgraduate School of Molecular Medicine at the Medical University of Warsaw in 2020 and became a board-certified radiation oncologist the same year. After completing his postdoctoral fellowship at the Dana-Farber Cancer Institute/Harvard Medical School in Boston, MA, USA, he returned to Poland in 2021. Upon his return, he was appointed as an Assistant Professor in the Department of Oncology and Radiotherapy at the Medical University of Gdańsk. His research focuses on the clinical, molecular, and physical aspects of radiotherapy. He serves on the management board of the STOPSTORM project (https://stopstorm.eu/) and coordinates the RAPSTAR study - a randomized phase III trial comparing stereotactic ablative radiotherapy with robotic-assisted partial nephrectomy in patients with renal cell carcinoma. Connect with him on LinkedIn.
In Dr. Tomasik’s view, a strong academic paper is built on three interconnected pillars: scientific rigor, clarity of communication, and contextual relevance. First, rigor ensures that the study is methodologically sound, reproducible, and transparent. Detailed descriptions of the design, materials, and analysis methods allow others to critically evaluate and replicate the work. Second, clarity makes even complex results understandable. Figures and tables should highlight the findings, and the text should follow a logical narrative flow. Finally, contextual relevance positions the work within the broader scientific landscape, explaining how it contributes to existing knowledge and why it matters. A well-written paper should not only present data but also guide readers through the reasoning that led to the conclusions. Importantly, it should also acknowledge limitations and potential biases, since honesty about weaknesses increases credibility. Ultimately, a good paper tells a story that is precise, meaningful, and able to inspire further investigation.
Dr. Tomasik asserts that authors should view themselves as both scientists and communicators when preparing a writing. Accuracy in reporting data is essential, but equally important is structuring the manuscript in a way that highlights the novelty and significance of the findings. Authors must be mindful of their audience: the goal is to make complex science understandable without oversimplifying. Ethical integrity is also crucial. This includes respecting authorship rules, disclosing conflicts of interest, and properly citing prior work to acknowledge contributions of others. Following journal guidelines helps save time and ensures a smoother peer-review process. Balancing ambition with humility is essential: present results enthusiastically but without exaggeration. Another key point is collaboration. Discussing drafts openly with co-authors can reveal blind spots and refine arguments. Finally, patience is vital. Effective writing involves multiple revisions, and the ability to revise critically often defines the quality and impact of the final paper.
“To fellow academic writers, I would say that your work is more impactful than you may realize. Each article, no matter how specific or technical, becomes part of the foundation on which future discoveries are built. Scientific progress is rarely a sudden leap; more often, it is the result of many careful, incremental steps taken by dedicated researchers. Writing may feel daunting at times, especially after rejections or critical reviews, but persistence transforms challenges into growth. Remember that clear communication is itself a form of service to the scientific community. By explaining your findings well, you make it possible for others to learn, replicate, and build upon your work. Treat writing not just as a duty but as an opportunity to shape dialogue in your field. Passion, honesty, and resilience will always shine through, and your contributions will continue to inspire progress, even beyond your immediate circle,” says Dr. Tomasik.
(by Sasa Zhu, Brad Li)
Antonio Ruggiero
Antonio Ruggiero is a pediatric oncologist and Professor at the Università Cattolica del Sacro Cuore in Rome, Italy, where he serves at the Fondazione Policlinico Universitario A. Gemelli IRCCS. His research focuses on pediatric neuro-oncology, supportive care in pediatric cancer patients, and innovative therapeutic approaches for childhood malignancies. Over the years, Dr. Ruggiero has dedicated his career to improving outcomes and quality of life for children with cancer through both clinical practice and translational research. His recent work emphasizes the development of personalized treatment strategies and the management of treatment-related complications in pediatric oncology. With numerous publications in peer-reviewed journals, he actively contributes to advancing knowledge in the field and is committed to multidisciplinary collaboration to enhance pediatric cancer care. Learn more about him here.
The key skill sets of an academic author, according to Dr. Ruggiero, include critical thinking and the ability to synthesize complex information from multiple sources. Clarity in communication is essential—being able to convey scientific concepts in a precise yet accessible manner ensures that research reaches and impacts the broader scientific community. Attention to detail is crucial for maintaining accuracy and rigor throughout the writing process. Additionally, perseverance and time management are vital, as academic writing often requires multiple revisions and balancing research with clinical or teaching responsibilities. Finally, collaboration and openness to feedback help refine one's work and foster meaningful scientific dialogue.
In Dr. Ruggiero’s view, avoiding bias requires conscious effort and methodological rigor. First, it is important to conduct comprehensive literature reviews that include diverse perspectives and sources, not just those that support a preconceived hypothesis. Maintaining objectivity when interpreting data and acknowledging limitations of one's research are essential practices. Peer review and collaboration with colleagues from different backgrounds can help identify unintentional biases. Additionally, being transparent about potential conflicts of interest and using standardized, validated methodologies help ensure that conclusions are evidence-based rather than influenced by personal or institutional preferences. Critical self-reflection throughout the writing process is also key to recognizing and mitigating bias.
“My primary motivation to write is the potential to improve the lives of children with cancer and their families. Every publication contributes to the collective knowledge that can lead to better treatments, reduced side effects, and ultimately, improved survival and quality of life. Academic writing allows me to share clinical insights and research findings with the global medical community, fostering collaboration and innovation. Additionally, I find fulfillment in mentoring the next generation of pediatric oncologists and researchers—publishing serves as a foundation for education and scientific progress. The responsibility we have as clinician-scientists to advance our field and give hope to our patients drives me to invest the necessary time and effort in rigorous, meaningful academic writing,” says Dr. Ruggiero.
(by Brad Li, Masaki Lo)
Nicole C. Schmitt
Nicole C. Schmitt, MD, FACS, is a Professor and the Vice Chair of Research in the Department of Otolaryngology – Head and Neck Surgery at Winship Cancer Institute. She is a surgeon-scientist, performing basic, clinical, and translational research aimed at discovering novel therapeutic combinations that enhance immune responses for head and neck cancer. The Schmitt Lab also focuses on repurposing drugs, particularly statin drugs used for hyperlipidemia, to prolong survival and reduced treatment-related toxicities in head and neck cancer. Follow her on X and Schmitt Lab’s website.
In Dr. Schmitt’s opinion, an author should critically evaluate the data and acknowledge the limitations of the data. Another key skill is to interpret the significance of the present study in the greater context of existing literature and research.
To avoid biases in her own writing, Dr. Schmitt would imagine for a minute that she is the peer reviewer of her own study, “What would I critique? What biases or limitations would I detect? Then I try to acknowledge these in the Discussion.”
“Contributing new information that may change how we think about a clinical or scientific problem is one of the greatest joys of academic life,” says Dr. Schmitt.
(by Brad Li, Masaki Lo)
Amanda Herrmann
Dr. Amanda Herrmann is an Assistant Clinical Professor of Medicine and Thoracic Medical Oncologist at the University of California San Diego (UCSD). She earned her medical degree from Rutgers Robert Wood Johnson Medical School and then completed Internal Medicine Residency and Chief Residency at the Keck School of Medicine of USC. In 2025, she completed her fellowship training in Hematology and Oncology at UCSD, where she also served as Chief Fellow prior to joining the faculty. Dr. Herrmann has a strong clinical and research interest in mutational analysis, targeted therapies, and mechanisms of resistance in non-small cell lung cancer. She is also interested in patient-centered clinical trial design and the characterization of time toxicity. In her growing practice, she is working to combine her commitments to compassionate patient care and collaborative clinical research with the goal of improving outcomes for patients with lung cancer. Follow her on X @AHerrmannMD.
TCR: What are the most commonly encountered difficulties in academic writing?
Dr. Herrmann: There is a vast amount of information at our fingertips. Academic authors are challenged to understand the full body of knowledge that exists in a particular area and identify questions that remain unanswered. In my opinion, the most challenging aspects of academic writing include cohesively presenting a complex topic and incorporating data synthesis and critical analysis in a way that provides value to others and moves the field beyond what is already known.
TCR: The burden of being a scientist/doctor is heavy. How do you allocate time to write papers?
Dr. Herrmann: While it may feel challenging as a clinician to allocate time to endeavors outside of patient care, sharing ideas through academic writing is necessary to drive progress in the field. In oncology in particular, many patients’ lives depend on scientific breakthroughs and therapeutic developments. I feel that being actively engaged in scientific research and academic writing enhances the patient-physician relationship and is a vital aspect of the practice of medicine.
TCR: What is fascinating about academic writing?
Dr. Herrmann: Academic writing in medicine fosters collaboration, perspective, and perseverance. It has the power to bring together diverse and innovative thinkers toward the common goal of improving patients’ lives.
(by Brad Li, Masaki Lo)
John Maher
Dr. John Maher is the scientific founder and Chief Scientific Officer of Leucid Bio, a CAR T-cell company spun out from King’s College London. He is also a clinical immunologist and leads the "CAR Mechanics" academic research group within King's College London. Many years ago, he played an important role in the development of second-generation (CD28) CAR technology while a visiting fellow at Memorial Sloan Kettering Cancer Center. Over the years, this approach has achieved significant clinical impact in the treatment of selected haematological malignancies. His research focuses on developing adoptive immunotherapy using CAR-engineered and gamma delta T-cells, primarily targeting solid tumor types. In addition, he is a consultant immunologist at Eastbourne Hospital.
Dr. Maher states that a truly good academic paper can only be recognized in hindsight, based on its impact within both the academic and broader community. An excellent example is the seminal work by Finney et al. in 1998 (https://pubmed.ncbi.nlm.nih.gov/9743337/), which was the first description of the transformative technology authors now refer to as second-generation chimeric antigen receptors. As a direct consequence of this work, academics in multiple centres validated the platform that he conceived, ultimately leading to the approval of several CAR T-cell drugs globally. In other words, the work's impact is what truly matters, not the journal's impact factor.
Dr. Maher believes that avoiding biases is entirely possible; however, authors may strive to present multiple sides of an argument. They are all humans with their own stories to tell. Authors can mitigate this tendency by avoiding hyperbole and overstatement, and by seeking feedback from colleagues who can review their writing and provide their honest perspectives. Another key pitfall is citation bias, providing a background that favours one side of an argument over another. In terms of disseminating an academic message, biased reporting of results is one of the strongest arguments in support of the independent peer review process.
“We are very privileged to work as a community in the pursuit of scientific discovery. An academic career is often challenging, in particular because of the difficulty in securing resources to make the research work. There will be many days when progress feels invisible! I have always believed that the key to success is perseverance. Moreover, writing is actually part of that discovery process. I generally find that it is only when I sit down to write a paper and assemble all the reams of data that the actual story becomes clearer in my head,” says Dr. Maher.
(by Sasa Zhu, Brad Li)